Ridding the pharma industry of crony capitalism
234 views · Published 29 August 2016 · 3:50 · Indexed 12 November 2026
Channel: Fox Business · 2016 · News & Politics
Michael Tanner, CATO Insititute senior fellow, discusses Mylan's recent EpiPen price controversy, the high cost of health care in the U.S., and possible free-market responses.